Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (37 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Smallcap 250 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quant Small Cap Fund |
|---|---|
| 07 Jan 2013 | ₹100.00 |
| 25 Feb 2014 | ₹107.86 |
| 16 Apr 2015 | ₹124.29 |
| 03 Jun 2016 | ₹134.93 |
| 23 Jul 2017 | ₹148.50 |
| 10 Sep 2018 | ₹151.57 |
| 30 Oct 2019 | ₹121.15 |
| 17 Dec 2020 | ₹208.17 |
| 04 Feb 2022 | ₹428.62 |
| 26 Mar 2023 | ₹423.12 |
| 13 May 2024 | ₹757.31 |
| 02 Jul 2025 | ₹830.85 |
| 20 Aug 2026 | ₹921.82 |
| Metric | quant · Direct NAV ₹314.43 Very High risk ★★★☆☆ | Category median Small Cap Fund · 37 funds |
|---|---|---|
| +13.35% | +12.86% | |
| +18.93% | +18.08% | |
| +21.18% | +18.44% | |
| +20.79% | +17.52% | |
| +17.72% | +19.96% | |
| +19.25% | — | |
| +21.18% | +21.45% | |
| +21.07% | +21.03% | |
| +19.75% | +19.53% | |
| Risk | ||
| 17.90% | 17.14% | |
| 0.69 | 0.69 | |
| 0.93 | 0.93 | |
| -46.71% | -32.37% | |
| Nifty Smallcap 250 | — | |
| +2.79% | +2.27% | |
| 0.88 | 0.86 | |
| 93.5% | 88.4% | |
| 80.8% | 77.8% | |
| 0.94% | 0.92% | |
| ₹30,875Cr | ₹4,512Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 0% | 27% | |
| Varun Pattani · 1.5y | — | |
| 07 Jan 2013 | — | |
| 97 | — | |
| 35.9% | — | |
| 12.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.